Results 221 to 230 of about 12,966 (296)

Comparison of Insertion Difficulties and Performance of Thoracoamniotic Shunts for Fetal Hydrothorax: Success and Failure Rates in Different Shunt Types for Fetal Hydrothorax. [PDF]

open access: yesPrenat Diagn
Treurniet TT   +26 more
europepmc   +1 more source

Disparity in the Markers of Affordability Across Targeted‐ and Immune‐Therapy Drugs Used in Head and Neck Cancers

open access: yesHead &Neck, Volume 48, Issue 7, Page 1876-1884, July 2026.
ABSTRACT Background The expanding use of systemic therapies for recurrent and metastatic head and neck cancer has raised major concerns regarding affordability and equitable access, particularly across countries with differing income levels and health financing structures.
Arjun Gurmeet Singh   +9 more
wiley   +1 more source

Repositories of biocultural diversity: Toward best practices for empowering ethnobotany in digital herbaria

open access: yesPLANTS, PEOPLE, PLANET, Volume 8, Issue 4, Page 1095-1103, July 2026.
Societal Impact Statement As herbaria digitize millions of plant specimens, ethnobotanical information associated with them is becoming increasingly accessible. These biocultural data include plant uses, names, and/or management practices of Indigenous Peoples and Local Communities (IPLCs).
Robbie Hart   +23 more
wiley   +1 more source

Connecting tradition and technology: The digitization of the ethnobotanical collection at the Rio de Janeiro Botanical Garden

open access: yesPLANTS, PEOPLE, PLANET, Volume 8, Issue 4, Page 1104-1115, July 2026.
The digitization of RBetno (JBRJ) represents a step forward for biodiversity conservation in Brazil. Aligned with the Kunming‐Montreal Global Biodiversity Framework (Target 2, 2020–2030), this project documents the use of plants, including traditional knowledge and vernacular names, with a focus on the Atlantic Forest and Amazon.
Viviane S. Fonseca‐Kruel   +6 more
wiley   +1 more source

Implications of Medicare Negotiation and Most-Favored-Nation Pricing for Cancer Medicine Costs.

open access: yesJAMA Health Forum
Hwang TJ   +3 more
europepmc   +1 more source

Regulated versus unregulated competition: How drug shortages boost illegal pharmacy sales

open access: yesStrategic Management Journal, Volume 47, Issue 7, Page 1811-1839, July 2026.
Abstract Research Summary This study examines how product shortages among legal firms create competitive opportunities for illegal firms. We analyze 713 drug shortages in the United States between 2017 and 2023 and show that shortages substantially increase illicit pharmacies’ sales of affected drugs, which rise by 40.5% during shortages and remain 32 ...
Luis Diestre, Benjamin Barber IV
wiley   +1 more source

Home - About - Disclaimer - Privacy